Cargando…
Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative
Diabetes Mellitus is one of the World Health Organization's priority diseases under research by the first and second programmes of Innovative Medicines Initiative, with the acronyms IMI1 and IMI2, respectively. Up to October of 2019, 13 projects were funded by IMI for Diabetes & Metabolic d...
Autores principales: | Brito, Maria de Fátima, Torre, Carla, Silva-Lima, Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290522/ https://www.ncbi.nlm.nih.gov/pubmed/34295913 http://dx.doi.org/10.3389/fmed.2021.688438 |
Ejemplares similares
-
The Innovative Medicines Initiative −10 Years of Public-Private Collaboration
por: Laverty, Hugh, et al.
Publicado: (2019) -
Introducing the MAVEN Leadership Training Initiative to diversify the scientific workforce
por: Wang, Y Claire, et al.
Publicado: (2021) -
Challenges in Nuclear Medicine: Innovative Theranostic Tools for Personalized Medicine
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2014) -
Editorial: The European Patients Academy on Therapeutic Innovation (EUPATI) Guidelines on Patient Involvement in Research and Development
por: Spindler, Per, et al.
Publicado: (2018) -
The Assessment of the Innovativeness of a New Medicine in Italy
por: Fortinguerra, Filomena, et al.
Publicado: (2021)